Fedorowicz, Z; van Zuuren, EJ; Hu, N (14 March 2012). “Histamine H2-receptor antagonists for urticaria.”. The Cochrane database of systematic reviews3: CD008596. doi:10.1002/14651858.CD008596.pub2. PMID22419335.
Clark, K.; Lam, L. T.; Gibson, S.; Currow, D. (2009). “The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials”. Anaesthesia64: 652–657. doi:10.1111/j.1365-2044.2008.05861.x.
Lightdale, J. R.; Gremse, D. A.; Heitlinger, L. A.; Cabana, M.; Gilger, M. A.; Gugig, R.; Hill, I. D. (2013). “Gastroesophageal reflux: management guidance for the pediatrician”. Pediatrics131 (5): e1684–e1695. doi:10.1542/peds.2013-0421.
Mitchell SL, Rockwood K. (2001). “The association between antiulcer medication and initiation of cobalamin replacement in older persons”. J Clin Epidemiol(英語版)54 (5): 531–534. doi:10.1016/S0895-4356(00)00340-1.
“Recent treatment with H2-antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection”. Br Med J308 (6922): 176. (1994). doi:10.1136/bmj.308.6922.176. PMID7906170.
Neal KR, Scott HM, Slack RC, Logan RF. (1996). “Omeprazole as a risk factor for Campylobacter gastroenteritis: Case-control study”. BMJ312 (7028): 414–415. doi:10.1136/bmj.312.7028.414. PMID8601113.
“Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?”. Curr Surg61 (5): 452–458. (2004). doi:10.1016/j.cursur.2004.03.014. PMID15475094.
Canani, RB; Cirillo, P; Roggero, P; Romano, C; Malamisura, B; Terrin, G; Passariello, A; Manguso, F; Morelli, L; Guarino, A; Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition, (SIGENP) (May 2006). “Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.”. Pediatrics117 (5): e817-20. doi:10.1542/peds.2005-1655. PMID16651285.
Canani, RB; Cirillo, P; Roggero, P (2006). “, "Therapy With Gastric Acidity Inhibitors Increases the Risk of Acute Gastroenteritis and Community-Acquired Pneumonia in Children”. Pediatrics117 (5): e817–20. doi:10.1542/peds.2005-1655. PMID16651285.
Guillet, R; Stoll, BJ; Cotten, CM (2006). “Association of H2-Blocker Therapy and Higher Incidence of Necrotizing Enterocolitis in Very Low Birth Weight Infants”. Pediatrics117 (2): 137–42. doi:10.1542/peds.2005-1543. PMID16390920.
Terrin, G; Passariello, A; De Curtis, M (2012). “Ranitidine Is Associated With Infections, Necrotizing Enterocolitis, and Fatal Outcome in Newborns”. Pediatrics129 (1): 40–5. doi:10.1542/peds.2011-0796. PMID22157140.
Fedorowicz, Z; van Zuuren, EJ; Hu, N (14 March 2012). “Histamine H2-receptor antagonists for urticaria.”. The Cochrane database of systematic reviews3: CD008596. doi:10.1002/14651858.CD008596.pub2. PMID22419335.
“Recent treatment with H2-antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection”. Br Med J308 (6922): 176. (1994). doi:10.1136/bmj.308.6922.176. PMID7906170.
Neal KR, Scott HM, Slack RC, Logan RF. (1996). “Omeprazole as a risk factor for Campylobacter gastroenteritis: Case-control study”. BMJ312 (7028): 414–415. doi:10.1136/bmj.312.7028.414. PMID8601113.
“Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?”. Curr Surg61 (5): 452–458. (2004). doi:10.1016/j.cursur.2004.03.014. PMID15475094.
Canani, RB; Cirillo, P; Roggero, P; Romano, C; Malamisura, B; Terrin, G; Passariello, A; Manguso, F; Morelli, L; Guarino, A; Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition, (SIGENP) (May 2006). “Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.”. Pediatrics117 (5): e817-20. doi:10.1542/peds.2005-1655. PMID16651285.
Canani, RB; Cirillo, P; Roggero, P (2006). “, "Therapy With Gastric Acidity Inhibitors Increases the Risk of Acute Gastroenteritis and Community-Acquired Pneumonia in Children”. Pediatrics117 (5): e817–20. doi:10.1542/peds.2005-1655. PMID16651285.
Guillet, R; Stoll, BJ; Cotten, CM (2006). “Association of H2-Blocker Therapy and Higher Incidence of Necrotizing Enterocolitis in Very Low Birth Weight Infants”. Pediatrics117 (2): 137–42. doi:10.1542/peds.2005-1543. PMID16390920.
Terrin, G; Passariello, A; De Curtis, M (2012). “Ranitidine Is Associated With Infections, Necrotizing Enterocolitis, and Fatal Outcome in Newborns”. Pediatrics129 (1): 40–5. doi:10.1542/peds.2011-0796. PMID22157140.
Mitchell SL, Rockwood K. (2001). “The association between antiulcer medication and initiation of cobalamin replacement in older persons”. J Clin Epidemiol(英語版)54 (5): 531–534. doi:10.1016/S0895-4356(00)00340-1.